Comparing Innovative and Traditional Ventilation Strategies on Atelectasis and Prognosis in Elderly Patients
Comparing the Effects of Innovative and Traditional Lung-protective Ventilation Strategies on the Occurrence of Perioperative Atelectasis and Prognosis in Elderly Patients: a Prospective, Randomized, Controlled Study
1 other identifier
interventional
304
1 country
3
Brief Summary
This study was divided into two parts, taking elderly patients undergoing general anesthesia surgery as the research subjects, through factorial design: 1. It was verified that in elderly patients undergoing general anesthesia surgery, innovative lung-protective ventilation strategies can reduce the occurrence of atelectasis and reduce the incidence of ventilator-related lung injury and postoperative pulmonary complications more than traditional lung-protective ventilation strategies; 2. On the basis of part one study proving that innovative lung-protective ventilation strategies can reduce the incidence of postoperative atelectasis and other complications in elderly patients undergoing general anesthesia surgery compared with traditional lung-protective ventilation strategies, further comparisons were made between the two factors of "positive pressure extubation" and "improved early postoperative respiratory training" in the innovative lung protective ventilation strategy, and whether there was an interaction between the two.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2021
Typical duration for not_applicable
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 28, 2021
CompletedFirst Submitted
Initial submission to the registry
August 2, 2023
CompletedFirst Posted
Study publicly available on registry
September 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2024
CompletedSeptember 1, 2023
August 1, 2023
2.2 years
August 2, 2023
August 28, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Volume ratio of new-onset atelectasis after surgery
After lung CT examination, the postoperative volume ratio of new atelectasis (new atelectasis volume/total lung volume) was calculated.
Pre-surgery;Approximately 24 hours after surgery
Secondary Outcomes (3)
postoperative pulmonary complications
Within 14 days after surgery; Within 30 days after surgery
specific indexes of ventilator-related lung injury
Pre-surgery;Immediately after the extubation;Approximately 24 hours after surgery
oxygenation index
Pre-surgery;20 minutes after the intubation;End of the operation;Approximately 10 minutes after the extubation;Approximately 40 minutes after the extubation;Approximately 70 minutes after the extubation;Approximately 24 hours after surgery
Study Arms (8)
Group of Control (Part I experiment)
SHAM COMPARATORTraditional ventilation strategies
Group of traditional lung-protective ventilation (Part I experiment)
EXPERIMENTALTraditional lung-protective ventilation strategies
Group of innovative lung-protective ventilation (Part I experiment)
EXPERIMENTALInnovative lung-protective ventilation strategies
Group of traditional & innovative ventilation (Part I experiment)
EXPERIMENTALTraditional \& innovative lung protection ventilation strategies
Group of Control (Part II experiment)
SHAM COMPARATOR1. lung-protective ventilation; 2. negative pressure extubation
Group of positive pressure extubation (Part II experiment)
EXPERIMENTAL1. lung-protective ventilation; 2. positive pressure extubation
Group of breathing training (Part II experiment)
EXPERIMENTAL1. lung-protective ventilation; 2. negative pressure extubation; 3. postoperative breathing training
Group of positive pressure extubation & breathing training (Part II experiment)
EXPERIMENTAL1. lung-protective ventilation; 2. positive pressure extubation; 3. postoperative breathing training
Interventions
1. Tidal volume:10ml/kg predicted body weight(PBW); 2. 0 cm H2O positive end expiratory pressure(PEEP); 3. negative pressure extubation
1. Tidal volume:6ml/kg PBW; 2. 5cmH2O PEEP; 3. Ventilator-controlled recruitment manoeuvre; 4. CPAP; 5. negative pressure extubation
1. Tidal volume:6ml/kg PBW; 2. 5cmH2O PEEP; 3. positive pressure extubation; 4. postoperative breathing training
1. Tidal volume:6ml/kg PBW; 2. 5cmH2O PEEP;
The suction tube is inserted into the endotracheal tube, continuous negative pressure suction, and at the same time that the balloon is completely deflated, the suction tube, dental pad and endotracheal intubation are pulled out at the same time, and then the patient is instructed to cough independently and remove sputum.
The adjustable pressure limiting(APL)was adjusted to 30cm H2O, and after the patient breathed spontaneously until the peak airway pressure reached 30cm H2O, and after maintaining this level for 10s, the balloon was quickly cut off to remove the endotracheal tube, so that the patient had an autonomous coughing action, and then the oral sputum was removed.
Inhale deeply through the nose, hold the breath for 5s, and then slowly spit out the breath through the mouth, cycle 5-6 times, and inflate the balloon. The above steps need to be performed 15 times within 24 hours after surgery.
Eligibility Criteria
You may qualify if:
- Elderly patients aged ≥ 60 years old who undergo laparoscopic abdominal surgery;
- Body mass index(BMI) \<30;
- American society of anesthesiologists physical status classification system(ASA):I-III;
- When the patient inhales air before surgery, SPO2≥94%;
- The duration of the operation is 2-7 hours, and the pneumoperitoneal pressure is 10-14mmHg.
You may not qualify if:
- Patients with acute respiratory distress syndrome or pulmonary hypertension (pulmonary systolic blood pressure ≥ 40mmHg) or bronchiectasis or lung malignant tumors
- Patients with acute respiratory infections within one month before surgery
- Patients who have undergone cardiopulmonary surgery
- Receiving invasive mechanical ventilation for more than 30min within 30 days before surgery
- Patients with peak airway pressure \> 35 cm H2O during intraoperative mechanical ventilation
- Patients with severe organic lesions of the heart such as obvious heart failure and coronary heart disease
- Patients with preoperative anemia (Hb\<10g/L)
- Patients with hypoproteinemia before surgery (albumin \< 35 g/L)
- Patients with tracheostomy and severe difficult airway
- Patients with sleep apnea syndrome
- Patients with intraoperative heavy bleeding (50% of the circulating blood volume is lost ≥ 3 hours)
- Patients with mental illness, impaired consciousness and communication disorders
- Patients who refuse to participate in this trial
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Fujian Medical University Union Hospital
Fuzhou, Fujian, China
The First Hospital of Putian
Putian, Fujian, China
The First Affiliated Hospital of Nanchang University
Nanchang, Jiangxi, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Zhongmeng Lai
Fujian Medical University Union Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 2, 2023
First Posted
September 1, 2023
Study Start
September 28, 2021
Primary Completion
December 1, 2023
Study Completion
June 1, 2024
Last Updated
September 1, 2023
Record last verified: 2023-08
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF
- Time Frame
- In June 2024, raw data was shared for 6 months.
- Access Criteria
- Accessible to any researcher
In June 2024, raw data was shared through ResMan(http://www.medresman.org.cn/login.aspx)